Renal ultrasound studies after endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux

Urology

Volumn 68, Issue 4, 2006, Pages 866-868

  Yu, Richard N ^a   Jones, Eric A ^a,b   Roth, David R ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BULKING AGENT; COPOLYMER; COTRIMOXAZOLE; DEXTRANOMER HYALURONIC ACID COPOLYMER; NITROFURANTOIN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; CONTROLLED STUDY; ECHOGRAPHY; ENDOSCOPIC THERAPY; FEMALE; FOLLOW UP; HUMAN; INFANT; INFECTION COMPLICATION; KIDNEY INJURY; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MICTURITION CYSTOURETHROGRAPHY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME; URETER OBSTRUCTION; VESICOURETERAL REFLUX;

CHILD, PRESCHOOL; DEXTRANS; ENDOSCOPY; GELS; HUMANS; HYALURONIC ACID; INJECTIONS; MICROSPHERES; TREATMENT OUTCOME; VESICO-URETERAL REFLUX;

EID: 33750325672     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.05.051     Document Type: Article

References (15)

1. Bailey R.R., Lynn K.L., and Robson R.A. End-stage reflux nephropathy. Ren Fail 16 (1994) 27-35
2. Lenaghan D., Whitaker J.G., Jensen F., et al. The natural history of reflux and long-term effects of reflux on the kidney. J Urol 115 (1976) 728-730
3. Riccabona M. Management of recurrent urinary tract infection and vesicoureteral reflux in children. Curr Opin Urol 10 (2000) 25-28
4. American Urological Association. Report of the management of primary vesicoureteral reflux in children. Clinical Practice Guidelines (1997), American Urological Association, Inc, Baltimore 1-100
5. Matouschek E. Treatment of vesicorenal reflux by transurethral Teflon-injection. Urologe A 20 (1981) 263-264
6. O'Donnell B., and Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. BMJ (Clin Res Ed) 289 (1984) 7-9
7. Stenberg A., and Lackgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short term clinical results. J Urol 154 (1995) 800-803
8. Stenberg A.M., Sundin A., Larsson B.S., et al. Lack of distant migration after injection of a 125-iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158 (1997) 1937-1941
9. Stenberg A., Larsson E., Lindholm A., et al. Injectable dextranomer-based implant: histopathology, volume changes and DNA analysis. Scand J Urol Nephrol 33 (1999) 355-361
10. Kirsch A.J., Perez-Brayfield M., Smith E.A., et al. The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171 (2004) 2413-2416
11. Elder J.S., Snyder H.M., Peters C., et al. Variation in practice among urologists and nephrologists treating children with vesicoureteral reflux. J Urol 148 (1992) 714-717
12. Charbonneau S.G., Tackett L.D., Gray E.H., et al. Is long-term sonographic followup necessary after uncomplicated ureteral reimplantation in children?. J Urol 174 (2005) 1429-1431
13. Puri P. Ten year experience with subureteral Teflon (polytetrafluoroethylene) injection (STING) in the treatment of vesico-ureteric reflux. Br J Urol 75 (1995) 126-131
14. Snodgrass W.T. Obstruction of a dysmorphic ureter following dextranomer/hyaluronic acid copolymer. J Urol 171 (2004) 295-296
15. Bedir S., Kilciler M., Ozgok Y., et al. Long-term complication due to dextranomer based implant: granuloma causing urinary obstruction. J Urol 172 (2004) 247-248